Bioceres Crop Solutions (NASDAQ:BIOX) PT Lowered to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target decreased by Oppenheimer from $16.00 to $13.00 in a report published on Monday, Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

A number of other analysts also recently issued reports on the stock. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Roth Mkm lowered their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Finally, Canaccord Genuity Group decreased their price objective on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, October 17th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Buy” and a consensus price target of $12.25.

Bioceres Crop Solutions Trading Down 3.9 %

Shares of BIOX stock opened at $6.98 on Monday. Bioceres Crop Solutions has a 12-month low of $6.98 and a 12-month high of $14.05. The firm has a market cap of $438.32 million, a P/E ratio of 705.00 and a beta of 0.47. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The company has a 50 day moving average of $8.76 and a 200-day moving average of $10.41.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. The business had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. Sell-side analysts anticipate that Bioceres Crop Solutions will post 0.39 earnings per share for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Bioceres Crop Solutions in the second quarter worth about $472,000. Fourth Sail Capital LP grew its holdings in Bioceres Crop Solutions by 20.5% in the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock worth $21,992,000 after purchasing an additional 334,195 shares during the period. Oppenheimer & Co. Inc. purchased a new stake in Bioceres Crop Solutions in the first quarter worth about $139,000. Wellington Management Group LLP grew its holdings in Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after purchasing an additional 7,096 shares during the period. Finally, Ping Capital Management Inc. purchased a new stake in Bioceres Crop Solutions in the second quarter worth about $448,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.